Childhood myopia has emerged as a global public health concern, with its prevalence rapidly increasing worldwide. Myopia is typically diagnosed in early childhood and often progresses throughout ...
CHAPERONE is Eyenovia’s Phase 3 study evaluating its proprietary drug-device combination of low-dose atropine in the Company’s Optejet dispensing platform as a potential treatment for ...